Vision
Keep all eyes healthy in our digitised world
Save Sight, Empower Lives
Mission
To better manage smart device use and eye health worldwide
plano, more than 20.20.
plano was developed with a clear purpose; to save sight and empower lives.
1.5 billion people across the world currently suffer from myopia (short-sightedness). This number is expected to rise exponentially to 5 billion people by 2050, 1 billion of whom will develop high myopia which often leads to blinding eye conditions and reduced quality of life.
The correlation of the onset of myopia with the rapid increase in excessive smart device use in children worldwide, is not the only adverse effect resulting from the shift in our lifestyle habits concurrent with an increasingly digitised world. The World Health Organisation (WHO) have officially classified internet addiction syndrome and gaming addiction as mental health conditions.
With a culture of disruptive thinking grounded in real scientific research, plano promotes the use of innovative technology to provide a solution to help mitigate the public health, societal and economic issues posed by these growing global trends.
The plano app is the first of its kind to provide a suite of child safety functions, while using science-based features to help modify behaviour in children to reduce myopia related risk factors and empower healthier device usage.
The innovative app comprises of carefully developed smart features empowering users to manage their children’s time spent on devices, correct face-to-screen-distance, good eye care habits, and device-free outdoor activity.
plano first launched in Singapore in 2017, where they have already generated over 500,000 downloads, established broad industry collaborations and partnered with Singapore’s Health Promotion Board, to drive awareness and education to over 320,000 Singaporean children in the next 12 months.
plano’s founding Managing Director Dr. Mo Dirani has dedicated his life to the study and research of myopia, and is an honorary Principal Investigator at the Singapore Eye Research Institute.
Board of Directors
Dr. Mo completed his PhD at the University of Melbourne, his MBA at the Australian Institute of Business (AIB) and is a graduate from the Australian Institute of Company Directors (AICD). He currently also holds an honorary Principal Investigator position at the Singapore Eye Research Institute (SERI), Singapore.
Daniel is an English and Singapore qualified solicitor with over 15 years' experience in cross-border and domestic corporate and banking law. The areas of his experience span from syndicated loans, structured finance to note issuances and regulatory matters.
Professor Crowston is a clinician-scientist and Professor of Ophthalmology at the Duke-NUS Medical School. He was the former Managing Director of the Centre for Eye Research Australia, Melbourne, Australia. He is a practising Ophthalmologist and leads world class translational research in glaucoma.
Executive Team
Dr. Mo completed his PhD at the University of Melbourne, his MBA at the Australian Institute of Business (AIB) and is a graduate from the Australian Institute of Company Directors (AICD). He currently also holds an honorary Principal Investigator position at the Singapore Eye Research Institute (SERI), Singapore.
Kevin is an MBA graduate from the Nanyang Business School, with a double degree in Strategy and International Management from the University of St. Gallen, Switzerland. Kevin read his undergraduate studies in Chemical Engineering from the National University of Singapore (NUS).
Over the last 15 years, Kelvin has done excellent work in scaling up the IT capabilities of both corporates and start-ups to be the best in their class. Prior to plano, Kelvin held various leadership positions and played an integral role in a start-up eventually listed on the mainboard of SGX.
Science & Innovation Advisory Group
Professor Wong is a retinal specialist with a clinical practice focusing on major retinal diseases, and leads nation-wide research studies. He has published >1,000 peer‐reviewed papers, given >300 invited plenary, symposium and named lectures globally.
Our Truly Awesome Partners.
We’ve worked with some truly incredible partners over the past 10 years.
